相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
Marc Morissette et al.
CELLS (2022)
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease
Ludovica Iovino et al.
ACTA NEUROPATHOLOGICA (2022)
A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease
Olivier Rascol et al.
MOVEMENT DISORDERS (2022)
Striatal glutamatergic hyperactivity in Parkinson's disease
F. Campanelli et al.
NEUROBIOLOGY OF DISEASE (2022)
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Divya Yadav et al.
NEUROCHEMISTRY INTERNATIONAL (2022)
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia
Valeria Calabrese et al.
NEUROPHARMACOLOGY (2022)
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease
Neus Rabaneda-Lombarte et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease
Qing Li et al.
CELL PROLIFERATION (2021)
Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice
Amandine Isenbrandt et al.
NEUROPHARMACOLOGY (2021)
Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra
Yunlong Zhang et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications
Marta Pajares et al.
CELLS (2020)
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
L. Iovino et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2020)
Molecular Mechanisms of Glutamate Toxicity in Parkinson's Disease
Ji Wang et al.
FRONTIERS IN NEUROSCIENCE (2020)
Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease
Xiaojuan Wu et al.
ACS CHEMICAL NEUROSCIENCE (2019)
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates
Delphine Charvin et al.
MOVEMENT DISORDERS (2018)
Metabotropic Glutamate Receptors in Glial Cells: A New Potential Target for Neuroprotection?
Simona Federica Spampinato et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Discovery, Structure-Activity Relationship, and Antiparkinsonian Effect of a Potent and Brain-Penetrant Chemical Series of Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Delphine Charvin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
mGluR4-containing corticostriatal terminals: synaptic interactions with direct and indirect pathway neurons in mice
Liliya Iskhakova et al.
BRAIN STRUCTURE & FUNCTION (2016)
The Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator ADX88178 Inhibits Inflammatory Responses in Primary Microglia
Ranjani Ponnazhagan et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
Neuroprotection in Parkinsonian-treated mice via estrogen receptor α activation requires G protein-coupled estrogen receptor 1
Melanie Bourque et al.
NEUROPHARMACOLOGY (2015)
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model
Tanya Chotibut et al.
MOLECULAR NEUROBIOLOGY (2014)
Direct and indirect pathways of basal ganglia: a critical reappraisal
Paolo Calabresi et al.
NATURE NEUROSCIENCE (2014)
Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra
Maxime Assous et al.
NEUROBIOLOGY OF DISEASE (2014)
Group III Metabotropic Glutamate Receptors: Pharmacology, Physiology and Therapeutic Potential
Marion S. Mercier et al.
NEUROCHEMICAL RESEARCH (2014)
Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state
D. Jantas et al.
NEUROPHARMACOLOGY (2014)
Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex
James Bogenpohl et al.
NEUROPHARMACOLOGY (2013)
Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
Khaled-Ezaheir Bennouar et al.
NEUROPHARMACOLOGY (2013)
Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease
Matthew J. Betts et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A Potent and Selective Metabotropic Glutamate Receptor 4 Positive Allosteric Modulator Improves Movement in Rodent Models of Parkinson's Disease
Emmanuel Le Poul et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment
Dario Cuomo et al.
JOURNAL OF NEUROCHEMISTRY (2009)
NEUROPROTECTIVE EFFECTS OF A SELECTIVE N-METHYL-D-ASPARTATE NR2B RECEPTOR ANTAGONIST IN THE 6-HYDROXYDOPAMINE RAT MODEL OF PARKINSON'S DISEASE
K. R. Leaver et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Downregulation of Glial Glutamate Transporters after Dopamine Denervation in the Striatum of 6-Hydroxydopamine-Lesioned Rats
E. K. Y. Chung et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4
Colleen M. Niswender et al.
MOLECULAR PHARMACOLOGY (2008)
Pharmacological activation of mGlu4 metabotropic glutamate receptors reduces nigrostriatal degeneration in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Giuseppe Battaglia et al.
JOURNAL OF NEUROSCIENCE (2006)
Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond
SA Lipton
NATURE REVIEWS DRUG DISCOVERY (2006)
Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons
O Valenti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes
HH Yao et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse
O Valenti et al.
JOURNAL OF NEUROSCIENCE (2003)
(-)-PHCCC, a positive allosteric modulator of mGluR4: characterization, mechanism of action, and neuroprotection
M Maj et al.
NEUROPHARMACOLOGY (2003)
Selective activation of mGlu4 metabotropic glutamate receptors is protective against excitotoxic neuronal death
V Bruno et al.
JOURNAL OF NEUROSCIENCE (2000)
分享论文
